General Information of the Compound
| Compound ID |
CP0040184
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[(4-fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-1,3-benzodiazol-2-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole
AlacanBrand of Astemizole
Alermizol
Alonga Brand of Astemizole
Alonga, Astemizol
Astemina
Astemisan
Astemisol
Astemison
Astemizol
Astemizol Alonga
Astemizol [German]
Astemizol [INN-Spanish]
Astemizol ratiopharm
Astemizole
Astemizole (JAN/USP/INN)
Astemizole Alacan Brand
Astemizole Alonga Brand
Astemizole Byk Brand
Astemizole Diba Brand
Astemizole Elfar Brand
Astemizole Esteve Brand
Astemizole Fustery Brand
Astemizole ICN Brand
Astemizole Janssen Brand
Astemizole Lesvi Brand
Astemizole McNeil Brand
Astemizole Medinsa Brand
Astemizole Merck Brand
Astemizole Senosiain Brand
Astemizole Septa Brand
Astemizole Smaller Brand
Astemizole Urbion Brand
Astemizole Vita Brand
Astemizole [USAN:BAN:INN]
Astemizole ratiopharm Brand
Astemizolum
Astemizolum [INN-Latin]
Astesen
Byk Brand of Astemizole
Diba Brand of Astemizole
Elfar Brand of Astemizole
Emdar
Esmacen
Esteve Brand of Astemizole
Fustermizol
Fustery Brand of Astemizole
GNF-PF-2461
HISMANAL (TN)
Hestazol
Hestazol, Kelp, Laridal, Retolen, Wareezol, HSBD 6799, BRN 4830190
Hismanal
Hismanal (TN)
Histamen
Histaminos
Histazol
Hubermizol
ICN Brand of Astemizole
Janssen Brand of Astemizole
Kelp
Laridal
Lesvi Brand of Astemizole
MJD-30
McNeil Brand of Astemizole
Medinsa Brand of Astemizole
Merck Brand of Astemizole
Metodih
Metodik
Nono-Nastizol A
Novo-mastizol A
Paralergin
R 42512
Ratiopharm Brand of Astemizole
Ratiopharm, Astemizol
Reig Jofre Brand of Astemizole
Retolen
Rifedot
Rimbol
Romadin
Senosiain Brand of Astemizole
Septa Brand of Astemizole
Simprox
Smaller Brand of Astemizole
Urbion Brand of Astemizole
Urdrim
Vita Brand of Astemizole
Wareezol
Waruzol
[3H]Astemizole
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H31FN4O
|
||||||||||||||||||
| Molecular Weight |
458.581
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(CCN2CCC(CC2)Nc2nc3ccccc3n2Cc2ccc(F)cc2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GXDALQBWZGODGZ-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
68844-77-9
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Protein ID: PT01685, ATP-dependent translocase ABCB1
Protein ID: PT06079, ATP-dependent translocase ABCB1
Protein ID: PT04542, Bile salt export pump
Protein ID: PT01206, Histamine H1 receptor
Protein ID: PT01711, Histamine H4 receptor
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT05367, Multidrug and toxin extrusion protein 1
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Protein ID: PT01196, Somatostatin receptor type 5
Clinical Information about the Compound